| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |